Chargement en cours...

The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice

BACKGROUND: Recent studies in the NOD (non-obese diabetic) mouse model of type 1 diabetes (T1D) support the notion that tyrosine kinase inhibitors have the potential for modulating disease development. However, the therapeutic effects of AG490 on the development of T1D are unknown. MATERIALS AND MET...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Davoodi-Semiromi, Abdoreza, Wasserfall, Clive H., Xia, Chang Qing, Cooper-DeHoff, Rhonda M., Wabitsch, Martin, Clare-Salzler, Michael, Atkinson, Mark
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351395/
https://ncbi.nlm.nih.gov/pubmed/22615750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0036079
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!